WEZLANA
Google image searchProduct monograph
Active ingredient
ustekinumab, 90 MG/1 ML
DIN: 02553309
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PRE-FILLED PEN
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 05-FEB-2025
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AC — Interleukin inhibitors (ATC, ATC/DDD)
- L04AC05 — USTEKINUMAB (ATC/DDD)
Reference brand drug: Stelara
